Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue.

Loria, Rossella; Vici, Patrizia; Di Lisa, Francesca Sofia; Soddu, Silvia; Maugeri-Saccà, Marcello; Bon, Giulia.

Loria R; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Vici P; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Di Lisa FS; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Soddu S; Medical Oncology A, Department of Radiological, Oncological, and Anatomo-Pathological Sciences, Umberto I University Hospital, University Sapienza, Rome, Italy.
Maugeri-Saccà M; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Bon G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Front Oncol ; 12: 1063651, 2022.

Article en En | MEDLINE | ID: mdl-36387137